专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20070246076A1 Methods for Prevention of Surface Adsorption of Biological Materials to Capillary Walls in Microchannels 有权
标题翻译：生物材料表面吸附微通道毛细管壁的方法
公开(公告)号：US20070246076A1
公开(公告)日：2007-10-25
申请号：US11772744
申请日：2007-07-02
申请人： Dean Hafeman , Aileen Zhou
发明人： Dean Hafeman , Aileen Zhou
IPC分类号： B08B9/00
CPC分类号： B08B17/00 , B01L3/502753 , B01L3/502761 , B01L3/561 , B01L2200/0647 , B01L2200/141 , B01L2300/161 , B01L2300/163 , B01L2300/165 , B01L2400/0415 , B01L2400/0487 , Y10S977/904 , Y10S977/92
摘要： Methods for reducing surface adsorption of biological materials to the walls of microfluidic conduits in microscale devices are provided. In an example of the methods, one or more colloidal-size particles, such as colloidal silica particles, are flowed in a fluid within the microfluidic conduit in the presence of one or more adherent biological materials (such as one or more proteins, cells, carbohydrates, nucleic acids, lipids and the like) to adsorb to the materials and prevent them from binding to the capillary walls of the microfluidic conduit. Other adsorption inhibition agents such as detergents and nonaqueous solvents can be used alone or in combination with colloidal particles to reduce surface adsorption in microfluidic conduits.
摘要翻译：提供了在微型装置中减少生物材料对微流体导管壁的表面吸附的方法。在所述方法的一个实例中，一种或多种胶体尺寸颗粒，例如胶体二氧化硅颗粒，在一种或多种粘附的生物材料（例如一种或多种蛋白质，细胞，碳水化合物，核酸，脂质等）吸附到材料上并防止它们结合到微流体导管的毛细管壁。其它吸附抑制剂如洗涤剂和非水溶剂可以单独使用或与胶体颗粒组合使用以减少微流体导管中的表面吸附。

2. 发明授权

US08178109B2 Compositions and methods of use for MGD-CSF in disease treatment 有权
标题翻译： MGD-CSF在疾病治疗中的组成和使用方法
公开(公告)号：US08178109B2
公开(公告)日：2012-05-15
申请号：US12370559
申请日：2009-02-12
申请人： Dirk Behrens , Elizabeth Bosch , Stephen K. Doberstein , Robert Forgan Halenbeck , Kevin Hestir , Min Mei Huang , Ernestine Lee , Haishan Lin , Thomas Linnemann , Shannon Marshall , Justin G. P. Wong , Ge Wu , Aileen Zhou , Cindy Leo , Lewis T. Williams
发明人： Dirk Behrens , Elizabeth Bosch , Stephen K. Doberstein , Robert Forgan Halenbeck , Kevin Hestir , Min Mei Huang , Ernestine Lee , Haishan Lin , Thomas Linnemann , Shannon Marshall , Justin G. P. Wong , Ge Wu , Aileen Zhou , Cindy Leo , Lewis T. Williams
IPC分类号： A61K39/00
CPC分类号： C07K16/243 , A61K38/00 , C07K14/53
摘要： Disclosed is a newly identified secreted molecule, identified herein as “monocyte, granulocyte, and dendritic cell colony stimulating factor” (MGD-CSF), the polypeptide sequence, and polynucleotides encoding the polypeptide sequence. Also provided is a procedure for producing the polypeptide by recombinant techniques employing, for example, vectors and host cells. Additionally, procedures are described to modify the disclosed novel molecules of the invention to prepare fusion molecules. Also disclosed are methods for using the polypeptides and active fragments thereof for treatment of a variety of diseases, including, for example, cancer, autoimmune and inflammatory diseases, infectious diseases, and recurrent pregnancy loss.
摘要翻译：公开了一种新鉴定的分泌型分子，本文称为“单核细胞，粒细胞和树突细胞集落刺激因子”（MGD-CSF），多肽序列和编码多肽序列的多核苷酸。还提供了通过使用例如载体和宿主细胞的重组技术产生多肽的方法。另外，描述了修饰所公开的本发明新颖分子以制备融合分子的方法。还公开了将多肽及其活性片段用于治疗各种疾病（包括例如癌症，自身免疫性和炎性疾病，感染性疾病和复发性妊娠损失）的方法。

3. 发明申请

US20070264277A1 Compositions and Methods of Use for Mgd-Csf in Disease Treatment 审中-公开
标题翻译：疾病治疗中Mgd-Csf的组成和使用方法
公开(公告)号：US20070264277A1
公开(公告)日：2007-11-15
申请号：US11632319
申请日：2005-07-21
申请人： Dirk Behrens , Elizabeth Bosch , Stephen Doberstein , Robert Halenbeck , Kevin Hestir , Min Huang , Ernestine Lee , Haishan Lin , Thomas Linnemann , Shannon Marshall , Justin Wong , Ge Wu , Aileen Zhou
发明人： Dirk Behrens , Elizabeth Bosch , Stephen Doberstein , Robert Halenbeck , Kevin Hestir , Min Huang , Ernestine Lee , Haishan Lin , Thomas Linnemann , Shannon Marshall , Justin Wong , Ge Wu , Aileen Zhou
IPC分类号： A61K39/00 , A61K38/00 , C07H21/00 , C07K14/00 , C07K16/18 , C12N15/00 , C12N15/87 , C12N5/06 , C12P1/00 , G01N33/53
CPC分类号： C07K16/243 , A61K38/00 , C07K14/53
摘要： Disclosed is a newly identified secreted molecule, identified herein as “monocyte, granulocyte, and dendritic cell colony stimulating factor” (MGD-CSF), the polypeptide sequence, and polynucleotides encoding the polypeptide sequence. Also provided is a procedure for producing the polypeptide by recombinant techniques employing, for example, vectors and host cells. Additionally, procedures are described to modify the disclosed novel molecules of the invention to prepare fusion molecules. Also disclosed are methods for using the polypeptides and active fragments thereof for treatment of a variety of diseases, including, for example, cancer, autoimmune and inflammatory diseases, infectious diseases, and recurrent pregnancy loss.
摘要翻译：公开了一种新鉴定的分泌型分子，本文称为“单核细胞，粒细胞和树突细胞集落刺激因子”（MGD-CSF），多肽序列和编码多肽序列的多核苷酸。还提供了通过使用例如载体和宿主细胞的重组技术产生多肽的方法。另外，描述了修饰所公开的本发明新颖分子以制备融合分子的方法。还公开了将多肽及其活性片段用于治疗各种疾病（包括例如癌症，自身免疫性和炎性疾病，感染性疾病和复发性妊娠损失）的方法。

4. 发明申请

US20120258071A1 Compositions and Methods of Use for MGD-CSF in Disease Treatment 有权
标题翻译： MGD-CSF在疾病治疗中的组成和使用方法
公开(公告)号：US20120258071A1
公开(公告)日：2012-10-11
申请号：US13446254
申请日：2012-04-13
申请人： Dirk Behrens , Elizabeth Bosch , Stephen K. Doberstein , Robert Forgan Halenbeck , Kevin Hestir , Min Mei Huang , Ernestine Lee , Haishan Lin , Thomas Linnemann , Shannon Marshall , Justin G. P. Wong , Ge Wu , Aileen Zhou , Cindy Leo , Lewis T. Williams
发明人： Dirk Behrens , Elizabeth Bosch , Stephen K. Doberstein , Robert Forgan Halenbeck , Kevin Hestir , Min Mei Huang , Ernestine Lee , Haishan Lin , Thomas Linnemann , Shannon Marshall , Justin G. P. Wong , Ge Wu , Aileen Zhou , Cindy Leo , Lewis T. Williams
IPC分类号： A61K38/19 , C07K17/02 , A61P35/00 , A61P37/00 , A61P31/00 , C07K17/00 , C07K19/00
CPC分类号： C07K16/243 , A61K38/00 , C07K14/53
摘要： Disclosed is a newly identified secreted molecule, identified herein as “monocyte, granulocyte, and dendritic cell colony stimulating factor” (MGD-CSF), the polypeptide sequence, and polynucleotides encoding the polypeptide sequence. Also provided is a procedure for producing the polypeptide by recombinant techniques employing, for example, vectors and host cells. Additionally, procedures are described to modify the disclosed novel molecules of the invention to prepare fusion molecules. Also disclosed are methods for using the polypeptides and active fragments thereof for treatment of a variety of diseases, including, for example, cancer, autoimmune and inflammatory diseases, infectious diseases, and recurrent pregnancy loss.
摘要翻译：公开了一种新鉴定的分泌型分子，本文鉴定为单核细胞，粒细胞和树突细胞集落刺激因子（MGD-CSF），多肽序列和编码多肽序列的多核苷酸。还提供了通过使用例如载体和宿主细胞的重组技术产生多肽的方法。另外，描述了修饰所公开的本发明新颖分子以制备融合分子的方法。还公开了将多肽及其活性片段用于治疗各种疾病（包括例如癌症，自身免疫性和炎性疾病，感染性疾病和复发性妊娠损失）的方法。

5. 发明授权

US07060171B1 Methods and systems for reducing background signal in assays 有权
标题翻译：用于降低测定中背景信号的方法和系统
公开(公告)号：US07060171B1
公开(公告)日：2006-06-13
申请号：US10202487
申请日：2002-07-24
申请人： Theo T. Nikiforov , Aileen Zhou
发明人： Theo T. Nikiforov , Aileen Zhou
IPC分类号： G01N27/447
CPC分类号： G01N27/44726
摘要： Methods and systems of monitoring reactions, e.g., assays, that filter out background signal from substrate, in detecting the product. The methods and systems controllably move detectable reaction product from a first location to a second location at which the product is detected while controllably moving potentially interfering substrate materials away from or not toward the second location. Controllable movement of the different species is accomplished through the controlled combination of bulk fluid flow and differential electrophoresis of substrate and product to move the product, but not the substrate past the detection region.
摘要翻译：在检测产品时监测反应的方法和系统，例如测定法，从底物过滤背景信号。所述方法和系统可控地将可检测的反应产物从第一位置移动到检测产物的第二位置，同时可控地将潜在的干扰性基底材料移动离开或不朝向第二位置移动。不同物种的可控运动通过大量流体流动和基板和产品的差分电泳的可控组合来实现，以移动产品，而不是通过检测区域的基板。

6. 发明申请

US20110003384A1 COMPOSITIONS AND METHODS OF USE FOR MGD-CSF IN DISEASE TREATMENT 有权
标题翻译： MGD-CSF在疾病治疗中的组合物和使用方法
公开(公告)号：US20110003384A1
公开(公告)日：2011-01-06
申请号：US12370559
申请日：2009-02-12
申请人： Dirk BEHRENS , Elizabeth Bosch , Stephen K. Doberstein , Robert Forgan Halenbeck , Kevin Hestir , Min Mei Huang , Ernestine Lee , Haishan Lin , Thomas Linnemann , Shannon Marshall , Justin G. P. Wong , Ge Wu , Aileen Zhou , Cindy Leo , Lewis T. Williams
发明人： Dirk BEHRENS , Elizabeth Bosch , Stephen K. Doberstein , Robert Forgan Halenbeck , Kevin Hestir , Min Mei Huang , Ernestine Lee , Haishan Lin , Thomas Linnemann , Shannon Marshall , Justin G. P. Wong , Ge Wu , Aileen Zhou , Cindy Leo , Lewis T. Williams
IPC分类号： C12N5/071
CPC分类号： C07K16/243 , A61K38/00 , C07K14/53
摘要： Disclosed is a newly identified secreted molecule, identified herein as “monocyte, granulocyte, and dendritic cell colony stimulating factor” (MGD-CSF), the polypeptide sequence, and polynucleotides encoding the polypeptide sequence. Also provided is a procedure for producing the polypeptide by recombinant techniques employing, for example, vectors and host cells. Additionally, procedures are described to modify the disclosed novel molecules of the invention to prepare fusion molecules. Also disclosed are methods for using the polypeptides and active fragments thereof for treatment of a variety of diseases, including, for example, cancer, autoimmune and inflammatory diseases, infectious diseases, and recurrent pregnancy loss.
摘要翻译：公开了一种新鉴定的分泌型分子，本文称为“单核细胞，粒细胞和树突细胞集落刺激因子”（MGD-CSF），多肽序列和编码多肽序列的多核苷酸。还提供了通过使用例如载体和宿主细胞的重组技术产生多肽的方法。另外，描述了修饰所公开的本发明新颖分子以制备融合分子的方法。还公开了将多肽及其活性片段用于治疗各种疾病（包括例如癌症，自身免疫性和炎性疾病，感染性疾病和复发性妊娠损失）的方法。

7. 发明申请

US20100281458A1 APPLICATION MODIFICATION FRAMEWORK 有权
标题翻译：应用修改框架
公开(公告)号：US20100281458A1
公开(公告)日：2010-11-04
申请号：US12433521
申请日：2009-04-30
申请人： Gaetano Paladino , Al J. Marcella , Kamal Nash , Aileen Zhou
发明人： Gaetano Paladino , Al J. Marcella , Kamal Nash , Aileen Zhou
IPC分类号： G06F9/44 , G06F17/30 , G06F15/16
CPC分类号： G06F8/71
摘要： Methods and apparatus for an application modification framework used in an integrated technology platform are shown, which allows hot deployment of modifications, including a modification component, a hot deployment component, and a package manager component. The framework provides various editors to allow a developer of the base application or a custom client application to edit files and features associated with the application. Managers are provided to control each of the editors and for maintenance of historical information to allow auditing and modification monitoring. Hot deployment controls the ability of the user to implement modifications and changes, wherein changes are identified as to origin and purpose, allowing smart debug to identify if error(s) occurred during custom modification, base modification or otherwise.
摘要翻译：示出了在集成技术平台中使用的应用修改框架的方法和装置，其允许热修改的部署，包括修改组件，热部署组件和包管理器组件。该框架提供各种编辑器，以允许基础应用程序的开发人员或自定义客户端应用程序编辑与应用程序相关联的文件和功能。提供管理员来控制每个编辑者和维护历史信息，以允许审计和修改监控。热部署控制用户实施修改和更改的能力，其中对起始和目的进行了更改，允许智能调试来识别在修改，基础修改或其他情况下是否发生错误。

8. 发明授权

US07252928B1 Methods for prevention of surface adsorption of biological materials to capillary walls in microchannels 有权
标题翻译：生物材料表面吸附微通道毛细管壁的方法
公开(公告)号：US07252928B1
公开(公告)日：2007-08-07
申请号：US10374759
申请日：2003-02-25
申请人： Dean G. Hafeman , Aileen Zhou
发明人： Dean G. Hafeman , Aileen Zhou
IPC分类号： G01N27/26
CPC分类号： B08B17/00 , B01L3/502753 , B01L3/502761 , B01L3/561 , B01L2200/0647 , B01L2200/141 , B01L2300/161 , B01L2300/163 , B01L2300/165 , B01L2400/0415 , B01L2400/0487 , Y10S977/904 , Y10S977/92
摘要： Methods for reducing surface adsorption of biological materials to the walls of microfluidic conduits in microscale devices are provided. In an example of the methods, one or more colloidal-size particles, such as colloidal silica particles, are flowed in a fluid within the microfluidic conduit in the presence of one or more adherent biological materials (such as one or more proteins, cells, carbohydrates, nucleic acids, lipids and the like) to adsorb to the materials and prevent them from binding to the capillary walls of the microfluidic conduit. Other adsorption inhibition agents such as detergents and nonaqueous solvents can be used alone or in combination with colloidal particles to reduce surface adsorption in microfluidic conduits.
摘要翻译：提供了在微型装置中减少生物材料对微流体导管壁的表面吸附的方法。在所述方法的一个实例中，一种或多种胶体尺寸颗粒，例如胶体二氧化硅颗粒，在一种或多种粘附的生物材料（例如一种或多种蛋白质，细胞，碳水化合物，核酸，脂质等）吸附到材料上并防止它们结合到微流体导管的毛细管壁。其它吸附抑制剂如洗涤剂和非水溶剂可以单独使用或与胶体颗粒组合使用以减少微流体导管中的表面吸附。

9. 发明授权

US08575312B2 Compositions and methods of use for MGD-CSF in disease treatment 有权
标题翻译： MGD-CSF在疾病治疗中的组成和使用方法
公开(公告)号：US08575312B2
公开(公告)日：2013-11-05
申请号：US13446254
申请日：2012-04-13
申请人： Dirk Behrens , Elizabeth Bosch , Stephen K. Doberstein , Robert Forgan Halenbeck , Kevin Hestir , Min Mei Huang , Ernestine Lee , Haishan Lin , Thomas Linnemann , Shannon Marshall , Justin G. P. Wong , Ge Wu , Aileen Zhou , Cindy Leo , Lewis T. Williams
发明人： Dirk Behrens , Elizabeth Bosch , Stephen K. Doberstein , Robert Forgan Halenbeck , Kevin Hestir , Min Mei Huang , Ernestine Lee , Haishan Lin , Thomas Linnemann , Shannon Marshall , Justin G. P. Wong , Ge Wu , Aileen Zhou , Cindy Leo , Lewis T. Williams
IPC分类号： C07K14/00
CPC分类号： C07K16/243 , A61K38/00 , C07K14/53
摘要： Disclosed is a newly identified secreted molecule, identified herein as “monocyte, granulocyte, and dendritic cell colony stimulating factor” (MGD-CSF), the polypeptide sequence, and polynucleotides encoding the polypeptide sequence. Also provided is a procedure for producing the polypeptide by recombinant techniques employing, for example, vectors and host cells. Additionally, procedures are described to modify the disclosed novel molecules of the invention to prepare fusion molecules. Also disclosed are methods for using the polypeptides and active fragments thereof for treatment of a variety of diseases, including, for example, cancer, autoimmune and inflammatory diseases, infectious diseases, and recurrent pregnancy loss.
摘要翻译：公开了一种新鉴定的分泌型分子，本文称为“单核细胞，粒细胞和树突细胞集落刺激因子”（MGD-CSF），多肽序列和编码多肽序列的多核苷酸。还提供了通过使用例如载体和宿主细胞的重组技术产生多肽的方法。另外，描述了修饰所公开的本发明新颖分子以制备融合分子的方法。还公开了将多肽及其活性片段用于治疗各种疾病（包括例如癌症，自身免疫性和炎性疾病，感染性疾病和复发性妊娠损失）的方法。

10. 发明授权

US08327351B2 Application modification framework 有权
标题翻译：应用修改框架
公开(公告)号：US08327351B2
公开(公告)日：2012-12-04
申请号：US12433521
申请日：2009-04-30
申请人： Gaetano Paladino , Al J. Marcella , Kamal Nash , Aileen Zhou
发明人： Gaetano Paladino , Al J. Marcella , Kamal Nash , Aileen Zhou
IPC分类号： G06F9/445
CPC分类号： G06F8/71
摘要： Methods and apparatus for an application modification framework used in an integrated technology platform are shown, which allows hot deployment of modifications, including a modification component, a hot deployment component, and a package manager component. The framework provides various editors to allow a developer of the base application or a custom client application to edit files and features associated with the application. Managers are provided to control each of the editors and for maintenance of historical information to allow auditing and modification monitoring. Hot deployment controls the ability of the user to implement modifications and changes, wherein changes are identified as to origin and purpose, allowing smart debug to identify if error(s) occurred during custom modification, base modification or otherwise.
摘要翻译：示出了在集成技术平台中使用的应用修改框架的方法和装置，其允许热修改的部署，包括修改组件，热部署组件和包管理器组件。该框架提供各种编辑器，以允许基础应用程序的开发人员或自定义客户端应用程序编辑与应用程序相关联的文件和功能。提供管理员来控制每个编辑者和维护历史信息，以允许审计和修改监控。热部署控制用户实施修改和更改的能力，其中对起始和目的进行了更改，允许智能调试来识别在修改，基础修改或其他情况下是否发生错误。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式